Laser capture microdissection-guided fluorescence in situ hybridization and flow cytometric cell cycle analysis of purified nuclei from-paraffin sections

Modern Pathology

Volumn 13, Issue 6, 2000, Pages 705-711

  DiFrancesco, Lisa M ^a,b   Murthy, Sabita K ^a   Luider, Joanne ^b   Demetrick, Douglas J ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

Author keywords

Cancer genetics; Flow cytometry; Fluorescence in situ hybridization; Laser capture microdissection; Ploidy

Indexed keywords

PARAFFIN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CELL CYCLE; CELL NUCLEUS; DISSECTION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE NUMBER; HUMAN; HUMAN TISSUE; ONCOGENE; PLOIDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033935814     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880120     Document Type: Article

References (47)

1. Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, et al. Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 1998; 16(4):1340-9.
2. Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer. Anticancer Res 1997;17(4B):3091-7.
3. Tsuda H, Sakamaki C, Tsugane S, Fukutomi T, Hirohashi S. A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases. Breast Cancer Res Treat 1998;48(1):21-32.
4. Ross JS, Sheehan C, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman R, et al. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization. Hum Pathol 1997;28(7):827-33.
5. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, et al. Correlation of c-erb-B2 amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1988;48:1238.
6. Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, et al. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 1993;53(10 Suppl):2199-203.
7. Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF. Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival. Cancer Res 1995;55(23):5693-8.
8. Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschmann R, Narayan P, et al. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol 1995;146(5):1131-9.
9. Reissmann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi S, et al. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene 1993;8(7):1913-9.
10. Borg A, Zhang QX, Aim P, Olsson H, Sellberg G. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 1992;52(10): 2991-4.
11. Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, et al. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992;52(7):1974-80.
12. Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, et al. p53 allele losses, mutations and expression in breast cancer and their relationship to clinicopathological parameters. Int J Cancer 1992;50(4):528-32.
13. Eccles DM, Brett L, Lessells A, Gruber L, Lane D, Steel CM, et al. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Br J Cancer 1992;65(1):40-4.
14. Kallioniemi O-P, Kallioniemi A, Kurisu W, Thor A, Chen L-C, Smith HS, et al. ERBB2 amplification in breast cancer analyzed by fluorescent in situ hybridization. Proc Natl Acad Sci USA 1992;89:5321.
15. Deng G, Yu M, Chen LC, Moore D, Kurisu W, Kallioniemi A, et al. Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction. Breast Cancer Res Treat 1996;40(3):271-81.
16. King WR, Gilchrist KW, Harris CP, Samson W, Meisner LF. FISH detection of HER-2/neu oncogene amplification in early onset breast cancer. Breast Cancer Res Treat 1996; 39(2):203-12.
17. Persons DL, Borelli KA, Hsu PH. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. Mod Pathol 1997;10(7): 720-7.
18. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 1997;15(8):2894-904.
19. Visscher DW, Wallis T, Ritchie CA. Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis. Cytometry 1995;21(1):95-100.
20. Kallioniemi A, Kallioniemi OP, Waldman FM, Chen LC, Yu LC, Fung YK, et al. Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization. Cytogenet Cell Genet 1992;60(3-4):190-3.
21. Papa V, Milazzo G, Goldfine ID, Waldman FM, Vigneri R. Sporadic amplification of the insulin receptor gene in human breast cancer. J Endocrinol Invest 1997;20(9):531-6.
22. Demetrick D. The use of archival frozen tumour tissue specimens for fluorescence in situ hybridization. Mod Pathol 1996;9:133-6.
23. Theodorescu D, Cornil I, Sheehan C, Man S, Kerbel RS. Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spread. Int J Cancer 1991;47:118-23.
24. Simpson JF, Quan DE, Ho JP, Slovak ML. Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization. Am J Pathol 1996;149(3): 751-8.
25. Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM, et al. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol 1996;149(4):1193-9.
26. McKay JA, Murray GI, Keith WN, McLeod HL. Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide. Mol Pathol 1997;50(6):322-5.
27. Heiden T, Wang N, Bernhard T. An improved Hedley method for preparation of paraffin-embedded tissues for flow-cytometric analysis of ploidy and S phase. Cytometry 1991;12:614-21.
28. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove CA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
29. Hyytinen E, Visakorpi T, Kallioniemi A, Kallioniemi OP, Isola JJ. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry 1994;16(2):93-9.
30. Baldetorp B, Stal O, Ahrens O, Cornelisse C, Corver W, Falkmer U, et al. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group. Cytometry 1998;33(4):385-93.
31. Wong SW, Rangan AM, Bilous AM, Boyages J, Gebski V, Benson EM. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting. Pathology 1999;31(2):90-4.
32. McCormick SR, Peters AA, Schrauth JB. Flow cytometric DNA analysis with cytokeratin gating of formalin-fixed deparaffinized breast cancer nuclei. Am J Clin Pathol 1998; 110(2):227-37.
33. Emmert-Buck MR, Bonner RF, Smith PD, Chuqui RF, Zhuang Z, Goldstein SR, et al. Laser capture microdissection. Science 1996;274:998-1001.
34. Sgroi DC, Teng S, Robinson G, LeVangie R, Hudson JR Jr, Elkahloun AG. In vivo gene expression profile analysis of human breast cancer progression. Cancer Res 1999;59(22): 5656-61.
35. Rajcan-Separovic E, Wang HS, Speevak MD, Janes L, Korneluk RG, Wakasa K, et al. Identification of the origin of double minutes in normal human cells by laser-based chromosome microdissection approach. Hum Genet 1995;96(1): 39-43.
36. Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, et al. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 1999; 110(2):94-102.
37. Banks RE, Dunn MJ, Forbes MA, Stanley A, Pappin D, Naven T, et al. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis - preliminary findings. Electrophoresis 1999;20(4-5):689-700.
38. Liehr T, Grehl H, Rautenstrauss B. FISH analysis of interphase nuclei extracted from paraffin-embedded tissue. Trends Genet 1995;11(10):377-8.
39. Taylor IW, Milthorpe BK. An evaluation of DNA fluorochromes, staining techniques, and analysis for flow cytometry: I. Unperturbed cell populations. J Histochem Cytochem 1980;28(11):1224-32.
40. Frierson HFJ, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC, et al. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 1995;103:195-8.
41. Mosiman VL, Patterson BK, Canterero L, Goolsby CL. Reducing cellular autofluorescence in flow cytometry: an in situ method. Cytometry 1997;30(3):151-6.
42. Szollosi J, Lockett SJ, Balazs M, Waldman FM. Autofluorescence correction for fluorescence in situ hybridization. Cytometry 1995;20(4):356-61.
43. Thompson CT, LeBoit PE, Nederlof PM, Gray JW. Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Am J Pathol 1994;144(2):237-43.
44. de Haas RR, Verwoerd NP, van der Corput MP, van Gijlswijk RP, Siitari H, Tanke HJ. The use of peroxidase-mediated deposition of biotin-tyramide in combination with time-resolved fluorescence imaging of europium chelate label in immunohistochemistry and in situ hybridization. J Histochem Cytochem 1996;44(10):1091-9.
45. Giercksky HE, Thorstensen L, Qvist H, Nesland JM, Lothe RA. Comparison of genetic changes in frozen biopsies and microdissected archival material from the same colorectal liver metastases. Diagn Mol Pathol 1997;6(6):318-25.
46. Pavelic J, Gall-Troselj K, Bosnar MH, Kardum MM, Pavelic K. PCR amplification of DNA from archival specimens. A methodological approach. Neoplasma 1996;43(2):75-81.
47. Wiegand P, Domhover J, Brinkmann B. [DNA degradation in formalin fixed tissues.] [German] Pathologe 1996;17(6):451-4.